EQS-News: M1 Kliniken AG: Strong Earnings Growth in 2024 – Strategic Focus on Global Market Leadership

M1 Kliniken AG: Strong Earnings Growth in 2024 – Strategic Focus on Global Market Leadership

Berlin, 21/05/2025 - M1 Kliniken AG (ISIN: DE000A0STSQ8) today published its annual report for the 2024 financial year. The M1 Group continued on its growth trajectory, driven in particular by the high-margin Beauty segment. Looking ahead, the company sees substantial growth potential: revenues in the Beauty segment are expected to reach between EUR 200 and 300 million by 2029, with a targeted EBIT margin of at least 20%. The strategic goal is to establish M1 Med Beauty as the leading global brand for aesthetic treatments. M1 is already the market leader in Europe – offering the highest medical standards at the best price. With the proposed dividend of EUR 0.50 per share, the Management Board and Supervisory Board reaffirm the Group’s dividend policy.

Key Financial Highlights 2024

• Group revenue increased by 7% to EUR 339.2 million (previous year: EUR 316.3 million)
• EBITDA rose by 52% to EUR 32.0 million (previous year: EUR 21.0 million)
• EBIT grew by 70% to EUR 26.8 million (previous year: EUR 15.7 million)
• EBT increased by 60% to EUR 26.3 million (previous year: EUR 16.4 million)
• Beauty segment revenue rose by 30% to EUR 91.7 million (previous year: EUR 70.8 million)
• Equity ratio improved from 67% to 71%

Significant Increase in Profitability and Cash Flow

The consolidated net profit after minority interests rose markedly to EUR 16.0 million in 2024 (previous year: EUR 10.3 million). Earnings per share increased accordingly from EUR 0.54 to EUR 0.85. Operating cash flow more than tripled to EUR 30.5 million (previous year: EUR 7.8 million), while free cash flow improved significantly to EUR 24.9 million, compared to EUR -1.5 million in the previous year.

The full Annual Report 2024 is available for download at www.m1-kliniken.de.

About M1 Kliniken AG

M1 Kliniken AG is the leading fully integrated provider of aesthetic medical healthcare services in Europe and Australia. The Group offers products and services of the highest quality standards in the aesthetic and surgical fields. M1 currently offers beauty treatments at 58 clinics under the "M1 Med Beauty" brand. The M1 Schlossklinik for Plastic and Aesthetic Surgery in Berlin is one of the largest and most modern facilities of its kind in Europe, with six operating theaters and 35 beds. M1 has been driving forward its internationalization since the end of 2018 and is currently represented in ten countries.